Read Time:11 Second
The trial aimed to help people living with hemophilia benefit from a single infusion that would allow them to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
